Azenta, Inc. (AZTA)

Market Cap	2.27B
Revenue (ttm)	656.32M
Net Income (ttm)	-164.17M
Shares Out	45.58M
EPS (ttm)	-3.09
PE Ratio	n/a
Forward PE	117.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	107,148
Open	50.60
Previous Close	50.43
Day's Range	49.62 - 50.97
52-Week Range	38.82 - 69.16
Beta	1.50
Analysts	Buy
Price Target	61.60 (+23.76%)
Earnings Date	Feb 5, 2025

About AZTA

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Feb 1, 1995
• Employees: 3,300
• Stock Exchange: NASDAQ
• Ticker Symbol: AZTA
• Website: https://www.azenta.com

Financial Performance

In 2024, Azenta's revenue was $656.32 million, a decrease of -1.32% compared to the previous year's $665.07 million. Losses were -$164.17 million, 1051.5% more than in 2023.

Analyst Forecast

According to 5 analysts, the average rating for AZTA stock is "Buy." The 12-month stock price forecast is $61.6, which is an increase of 23.76% from the latest price.

Price Target

$61.6

(23.76% upside)

Analyst Consensus: Buy